SENSEX NIFTY
Bal Pharma Quarterly Results, Bal Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Bal Pharma
Bal Pharma
BSE: 524824|NSE: BALPHARMA|ISIN: INE083D01012|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
, 16:01
67.65
1.4 (2.11%)
VOLUME 10,644
LIVE
NSE
, 16:01
67.90
1.7 (2.57%)
VOLUME 39,385
Download Annual Report PDF Format 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Bal Pharma

------------------- in Rs. Cr. -------------------
Jun '14 Mar '14 Dec '13 Sep '13 Jun '13
Net Sales/Income from operations 41.45 46.62 43.28 46.76 36.76
Other Operating Income 0.89 2.45 0.98 1.09 0.94
Total Income From Operations 42.34 49.07 44.25 47.85 37.70
EXPENDITURE
Consumption of Raw Materials 22.65 24.35 22.20 24.78 17.79
Purchase of Traded Goods 1.07 1.44 1.45 1.52 0.75
Increase/Decrease in Stocks -1.93 1.07 -0.13 0.61 -0.59
Power & Fuel -- -- -- -- --
Employees Cost 7.64 7.45 7.14 6.98 6.55
Depreciation 1.12 1.02 1.11 1.09 1.52
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 8.91 10.35 9.05 9.45 8.78
P/L Before Other Inc. , Int., Excpt. Items & Tax 2.88 3.39 3.44 3.41 2.90
Other Income 0.06 0.37 0.05 0.15 0.08
P/L Before Int., Excpt. Items & Tax 2.94 3.76 3.48 3.56 2.98
Interest 1.63 1.82 1.77 1.75 1.82
P/L Before Exceptional Items & Tax 1.32 1.94 1.71 1.81 1.16
Exceptional Items -- -- -- -- --
P/L Before Tax 1.32 1.94 1.71 1.81 1.16
Tax 0.33 0.59 0.32 0.40 0.25
P/L After Tax from Ordinary Activities 0.98 1.36 1.39 1.41 0.91
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 0.98 1.36 1.39 1.41 0.91
Equity Share Capital 12.87 11.11 10.57 10.57 10.57
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.78 1.25 1.32 1.33 0.86
Diluted EPS 0.78 1.21 1.32 1.33 0.86
EPS After Extra Ordinary
Basic EPS 0.78 1.25 1.32 1.33 0.86
Diluted EPS 0.78 1.21 1.32 1.33 0.86
Public Share Holding
No Of Shares (Crores) 0.66 0.51 0.51 0.51 0.51
Share Holding (%) 51.17 46.28 48.63 48.63 48.63
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 0.63 0.60 0.54 0.54 0.54
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 48.83 53.72 51.37 51.37 51.37
Notes
Source : Dion Global Solutions Limited

Results of Bal Pharma

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for balpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.